|
|
Binance |
|
|
Coinbase |
|
|
KUCOIN |
|
|
AscendEX (Formally BitMax) |
By Trader Edge at 2026-09-08 18:35
Sentiment: Positive
TLDR AbbVie completed its acquisition of Apogee Therapeutics for $135.11 per share in cash, totaling approximately $10.9 billion Apogeeās lead drug, zumilokibart, targets IL-13 and showed about two-thirds of atopic dermatitis patients achieved skin clearance in Phase 2 trials The pipeline also includes APG273, a combination therapy targeting both IL-13 and TSLP for asthma treatment [...] The post AbbVie (ABBV) Stock: What the $10.9 Billion Apogee Deal Means for Earnings and Pipeline appeared first on CoinCentral. Continue reading...
Categories: Stocks
Tags: #Stocks
Source Coin Central